Amprius Q3 2026 Revenue Tops Estimates at $39.1M, but EPS Misses at -$0.02
Revenue of $39.1M vs. $35.8M expected and adjusted EPS of -$0.02 vs. -$0.01; revenue up 83% from a year earlier.
Amprius (AMPX) posted mixed third-quarter 2026 results, with revenue above the estimate and adjusted EPS below it. Revenue was $39.1 million, up 83% from a year earlier, above the $35.8 million estimate, and adjusted EPS was -$0.02, up 33% from a year earlier, below the -$0.01 estimate.
Shares fell 0.4% in after-hours trading as of 4:05 p.m. ET, to $9.13 from a $9.16 close.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | -$0.01 | -$0.02 | Miss by 57% |
| Revenue | $35.8M | $39.1M | Beat by 9.3% |
| Change | YoY | QoQ |
|---|---|---|
| Adjusted EPS | ▲ 33% | ▲ 33% |
| Revenue | ▲ 83% | ▲ 15% |
By our calculation, revenue was $3.3 million above the estimate and adjusted EPS was $0.01 below it. The QoQ column compares with the previous quarter's revenue of $34.0 million and adjusted EPS of -$0.03. The YoY column compares with $21.4 million and -$0.03 in the same quarter a year earlier.
Track record
- EPS record. Adjusted EPS beat the estimate in 5 of the last 8 reports, including this one.
- Revenue record. Revenue beat the estimate in 6 of the last 8 reports.
- Revenue trend. Revenue over the last 5 reports, oldest first: $21.4 million, $25.2 million, $28.5 million, $34.0 million and $39.1 million.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $0.01 and revenue of $42.2 million next quarter, based on 6 analysts.
- Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 83% increase to $39.1 million.
- Estimate record. Whether Amprius extends a record of beating EPS estimates in 5 of its last 8 reports.
- Related coverage. See our reports on CoreWeave, Anterix, Lumexa Imaging and Permian Basin Royalty Trust.
Sources: Results are from Amprius's Nov. 10, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Amprius's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
CoreWeave Tops Q3 2026 Estimates as Revenue Rises 168% to $3.66B
EarningsAnterix Fiscal Q2 2027 EPS Tops Estimates at -$0.25, but Revenue Misses at $2.0M
EarningsLumexa Imaging Beats Q3 2026 Estimates as Revenue Rises 4.6% to $272.0M
EarningsPermian Basin Royalty Trust Q3 2026 Revenue Falls 32% to $5.0M
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.
